Novel Mannich bases of ciprofloxacin with improved physicochemical properties, antibacterial, anticancer activities and caspase-3 mediated apoptosis

被引:36
作者
Abdel-Rahman, Islam M. [1 ]
Mustafa, Muhamad [1 ]
Mohamed, Soad A. [2 ]
Yahia, Ramadan [3 ]
Abdel-Aziz, Mohamed [4 ]
Abuo-Rahma, Gamal El-Din A. [1 ,4 ]
Hayallah, Alaa M. [1 ,5 ,6 ]
机构
[1] Deraya Univ, Fac Pharm, Dept Pharmaceut Chem, New Minia 61519, Minia, Egypt
[2] Deraya Univ, Fac Pharm, Dept Pharmaceut, New Minia 61519, Minia, Egypt
[3] Deraya Univ, Fac Pharm, Dept Microbiol, New Minia 61519, Minia, Egypt
[4] Minia Univ, Fac Pharm, Dept Med Chem, Al Minya 61519, Egypt
[5] Assiut Univ, Fac Pharm, Pharmaceut Organ Chem, Assiut, Egypt
[6] Sphinx Univ, Fac Pharm, Dept Pharmaceut Chem, New Assiut, Egypt
关键词
Mannich base; Ciprofloxacin; Physicochemical properties; Antibacterial; Anticancer; Caspase; 3; TRANSITIONAL-CELL CARCINOMA; CYCLE ARREST; PROLIFERATION; SOLUBILITY; GROWTH; DERIVATIVES; CANCER; CYTOTOXICITY; INHIBITION; ASSAY;
D O I
10.1016/j.bioorg.2021.104629
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The design, synthesis and identification of a novel series of Mannich bases of ciprofloxacin was reported. Naphthol derivatives 2a and 2b showed highly potent cytotoxic activity among the tested compounds. Compound 2a showed broad spectrum antiproliferative activity with GI(50) of 2.5-6.79 mu M with remarkable selectivity towards renal and prostate cancers with selectivity ratios ranging from 0.17 to 6.79. Independently, 2a showed outstanding activity against colon cancer HOP-92 cell lines with IC50 of 6.66 mu M while 2b showed highly potent activity against ovarian cancer cell lines with IC50 of 0.97 mu M. Results showed that 2b induced cell cycle arrest at G2/M phase and apoptosis; compound 2b showed over-expression of caspase-3 protein level (449.2 +/- 7.95) compared to doxorubicin (578.7 +/- 14.4 pg/mL). Meanwhile, compounds 2a and 2b experienced outstanding activity against both Gram-positive and Gram-negative microorganisms. Interestingly, compound 2j experienced high activity against Escherichia coli and Pseudomonas aeruginosa with MIC of 0.036 and 0.043, respectively. Compound 2d revealed 27 folds and 22 folds, respectively increasing of activity over ciprofloxacin against Staphylococcus aureus and MRSA(reference strain). Compound 2d showed high activity against Staphylococcus aureus, MRSA (reference strain) and MRSA (clinical strain) with MIC of 0.57, 0.52, 0.082 mu g/mL, respectively. Interestingly, the most active tested compounds were found to have promising physicochemical and drug likeness properties. The Mannich bases 2j, 2d and 2g showed promising antibacterial activities, while naphthols 2a and 2b showed promising antiproliferative and antibacterial activities that require further optimization.
引用
收藏
页数:14
相关论文
共 45 条
[1]  
Abdel-Aal M., 2019, J MOD RES, V1, P1, DOI 10.21608/jmr.2019.12650.1001
[2]   Novel N-4-piperazinyl-ciprofloxacin-chalcone hybrids: Synthesis, physicochemical properties, anticancer and topoisomerase I and II inhibitory activity [J].
Abdel-Aziz, Mohamed ;
Park, So-Eun ;
Abuo-Rahma, Gamal El-Din A. A. ;
Sayed, Mohamed A. ;
Kwon, Youngjoo .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 69 :427-438
[3]   Design, synthesis, antibacterial activity and physicochemical parameters of novel N-4-piperazinyl derivatives of norfloxacin [J].
Abuo-Rahma, Gamal El-Din A. A. ;
Sarhan, Hatem. A. ;
Gad, Gamal F. M. .
BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (11) :3879-3886
[4]   Modification of 7-piperazinylquinolone antibacterials to promising anticancer lead compounds: Synthesis and in vitro studies [J].
Ahadi, Hamideh ;
Emami, Saeed .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 187
[5]  
Aranha O, 2000, CLIN CANCER RES, V6, P891
[6]   Reducing the peptidyl features of caspase-3 inhibitors: A structural analysis [J].
Becker, JW ;
Rotonda, J ;
Soisson, SM ;
Aspiotis, R ;
Bayly, C ;
Francoeur, S ;
Gallant, M ;
Garcia-Calvo, M ;
Giroux, A ;
Grimm, E ;
Han, YX ;
McKay, D ;
Nicholson, DW ;
Peterson, E ;
Renaud, J ;
Roy, S ;
Thornberry, N ;
Zamboni, R .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (10) :2466-2474
[7]   INFECTION IN CANCER-PATIENTS - A CONTINUING ASSOCIATION [J].
BODEY, GP .
AMERICAN JOURNAL OF MEDICINE, 1986, 81 (1A) :11-26
[8]   Targeting apoptotic caspases in cancer [J].
Boice, Ashley ;
Bouchier-Hayes, Lisa .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2020, 1867 (06)
[9]   Solubility behavior and biopharmaceutical classification of novel high-solubility ciprofloxacin and norfloxacin pharmaceutical derivatives [J].
Breda, Susana A. ;
Jimenez-Kairuz, Alvaro F. ;
Manzo, Ruben H. ;
Olivera, Maria E. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2009, 371 (1-2) :106-113
[10]   Synthesis and pharmacological exploitation of clioquinol-derived copper-binding apoptosis inducers triggering reactive oxygen species generation and MAPK pathway activation [J].
Chen, Hui-Ling ;
Chang, Chun-Yi ;
Lee, Hsun-Tzu ;
Lin, Hua-Hsuan ;
Lu, Pei-Jung ;
Yang, Chia-Ning ;
Shiau, Chung-Wai ;
Shaw, Arthur Y. .
BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (20) :7239-7247